Skip to main content

Table 5 In vitro drug release study of the 9 batches of microspheres

From: Pharmacoscintigraphic evaluation and antidiabetic efficacy of gliclazide-loaded 99mTc-labelled mucoadhesive microspheres

 

F1

F2

F3

F4

F5

F6

F7

F8

F9

0

0

0

0

0

0

0

0

0

0

1

10.47

16.21

13.25

14.21

15.87

17.42

14.55

12.28

13.23

2

13.92

21.42

16.67

19.5

18.27

25.93

21.53

21.34

19.45

3

19.63

25.32

21.36

24.63

27.9

35.59

29.53

28.8

27.66

4

24.2

31.82

24.68

32.8

32.62

47.46

39.34

39.54

38.48

5

28.14

37.21

28.18

38.73

38.85

56.58

44.5

46.45

49.9

6

35.81

43.81

34.41

43.21

43.17

60.22

52.26

54.32

55.65

7

42.16

48.21

41.37

49.98

51.39

67.64

59.36

60.86

63.32

8

48.33

54.31

47.54

54.72

60.42

75.27

64.66

68.88

69.19

9

54.42

61.88

54.83

61.24

68.25

82.19

71.48

72.1

73.54

10

59.56

67.21

62.74

66.65

74.76

87.33

83.4

75.58

76.55

11

66.25

71.58

69.14

72.37

80.56

91.43

85.5

80.45

78.58

12

75.4

78.87

76.87

81.1

86.25

97.44

90.55

88.66

81.2

  1. *Values are indicated as percent (%) cumulative drug release